CDC42 and glioblastoma: The mechanisms modifying the expression of immunoactive molecules in conditioned PCs have not yet been determined, but they could be a consequence of changes in cell polarity due to transcription regulatory signals, including Cdc42 transfer from GBM cancer cells through cytoneme-like flectopodia [8].